stella
beta
Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients — Stella
Recruiting
Back to Hereditary Angioedema (HAE) trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
Institute For Asthma & Allergy, Wheaton, Maryland
View full record on ClinicalTrials.gov